Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Free Cash Flow Growth
19.62%
TTM · Period ending:
ARMP Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported19.62%period ending
Latest reported19.62%period ending
ARMP TTM Free Cash Flow YoY % (-21.74% → 19.62%)
Year-over-year change
High-resolution chart · PNG
ARMP free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 19.6248% | |
| 32.5403% | |
| 33.2868% | |
| 34.8263% | |
| 30.3589% | |
| 22.5241% | |
| 29.0406% | |
| 23.6064% | |
| 13.896% | |
| 7.3237% | |
| -60.1724% | |
| -64.5097% | |
| -95.2749% | |
| -121.0308% | |
| -39.4429% | |
| -47.3879% | |
| -29.6698% | |
| -11.3292% | |
| -30.2975% | |
| -49.7167% | |
| -34.4786% | |
| -17.2195% | |
| -20.8022% | |
| 2.0081% | |
| -28.4069% | |
| -105.6475% | |
| -67.6851% | |
| -65.0714% | |
| -39.8378% | |
| 10.1772% | |
| -1.9027% | |
| -12.2652% | |
| 19.6309% | |
| 13.6036% | |
| 14.8877% | |
| 28.8221% | |
| 2.7068% | |
| -1.1707% | |
| -8.7779% | |
| -7.3021% | |
| -1.7636% | |
| 11.0674% | |
| 27.4648% | |
| 16.0181% | |
| 14.6228% | |
| -17.8892% | |
| -82.4371% | |
| -249.3029% | |
| -386.0053% | |
| -295.0745% | |
| 50.2955% | |
| 16.4033% | |
| 40.5185% | |
| 22.194% | |
| 11.2483% | |
| -9.9808% | |
| -24.369% | |
| -21.1317% | |
| 1.6507% | |
| 29.9878% | |
| 28.1739% | |
| 31.3189% | |
| 27.2754% | |
| 8.5569% | |
| -3.6641% | |
| -7.0868% | |
| 1.0338% | |
| -12.8636% | |
| -6.421% | |
| -37.9785% | |
| -43.4847% | |
| -17.9755% | |
| -3.0819% | |
| 44.1115% | |
| 47.1271% | |
| 48.1584% | |
| 47.4487% | |
| 26.0964% | |
| -0.7208% | |
| -96.8752% | |
| -309.4792% | |
| -721.5668% | |
| -685.3019% | |
| -13.0573% | |
| 45.4704% | |
| 72.7798% | |
| 56.4521% | |
| -70.9656% | |
| -90.1635% | |
| -108.3333% | |
| 49.2424% | |
| 47.1545% | |
| 48% | |
| 54.5455% | |
| -7.3171% | |
| 0.8065% | |
| -0.8065% | |
| -10.9244% | |
| -11.8182% | |
| -10.7143% |